# Pierre Fabre Pharmaceuticals, Inc. – FDA Inspection, Nov 1, 2024

Source: https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/01cb2931-62ce-4bde-84b6-ab813b5e54a6
Source feed: FDA_Inspections

> FDA inspection 1253273 of Pierre Fabre Pharmaceuticals, Inc., November 01, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253273
- Company Name: Pierre Fabre Pharmaceuticals, Inc.
- Inspection Date: 2024-11-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1175515 - 2022-07-27](https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/5e316c74-1c4a-4b0e-8a3f-5c9b20cfd3fd)
- [FDA Inspection 956345 - 2015-12-30](https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/140fdda4-ba34-4f68-82d6-163a0645a609)

## Related Officers

- [Meredith L. Miller](https://www.keypedia.com/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)

Company: https://www.keypedia.com/companies/pierre-fabre-pharmaceuticals-inc/ee0282e8-44f7-43c1-b3d5-fdc0c75129dc

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248